126 related articles for article (PubMed ID: 9413086)
1. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
Wandel G
Vaccine; 1997 Dec; 15(17-18):1815. PubMed ID: 9413086
[No Abstract] [Full Text] [Related]
2. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
Arya SC
Vaccine; 1997 Feb; 15(2):244. PubMed ID: 9066045
[No Abstract] [Full Text] [Related]
3. Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply.
Keddy KH; Klugman KP; Robbins JB
Vaccine; 1998; 16(9-10):871-2. PubMed ID: 9682329
[No Abstract] [Full Text] [Related]
4. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
[TBL] [Abstract][Full Text] [Related]
5. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
6. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
Hessel L; Debois H; Fletcher M; Dumas R
Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
[TBL] [Abstract][Full Text] [Related]
7. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
Pulickal AS; Pollard AJ
Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
[No Abstract] [Full Text] [Related]
8. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
9. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
[TBL] [Abstract][Full Text] [Related]
10. [Conjugate vaccines against bacterial infections: typhoid fever].
Paniagua J; García JA; López CR; González CR; Isibasi A; Kumate J
Salud Publica Mex; 1992; 34(3):268-73. PubMed ID: 1377407
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine].
Wang ZG; Zhou WZ; Shi J
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Feb; 18(1):26-9. PubMed ID: 9812477
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
Kim YR; Yoo JH; Hur JK; Kang JH; Shin WS; Kang MW
J Korean Med Sci; 1995 Oct; 10(5):314-7. PubMed ID: 8750055
[TBL] [Abstract][Full Text] [Related]
13. A Salmonella typhi Vi conjugate vaccine.
Koul PA
N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
[No Abstract] [Full Text] [Related]
14. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
Tacket CO; Ferreccio C; Robbins JB; Tsai CM; Schulz D; Cadoz M; Goudeau A; Levine MM
J Infect Dis; 1986 Aug; 154(2):342-5. PubMed ID: 2425009
[No Abstract] [Full Text] [Related]
15. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
Klugman KP; Gilbertson IT; Koornhof HJ; Robbins JB; Schneerson R; Schulz D; Cadoz M; Armand J
Lancet; 1987 Nov; 2(8569):1165-9. PubMed ID: 2890805
[TBL] [Abstract][Full Text] [Related]
16. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
Robbins JD; Robbins JB
J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.
Keddy KH; Klugman KP; Hansford CF; Blondeau C; Bouveret le Cam NN
Vaccine; 1999 Jan; 17(2):110-3. PubMed ID: 9987143
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.
Singh M; Ganguly NK; Kumar L; Vohra H
Microbiol Immunol; 1999; 43(6):535-42. PubMed ID: 10480549
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
[TBL] [Abstract][Full Text] [Related]
20. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
Hall CB
Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
